UZEDY
NDC 51759-850, risperidone, injection, suspension, extended release, from Teva Pharmaceuticals USA, Inc..
- Product NDC
- 51759-850
- Status
- Listed
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Dosage form
- INJECTION, SUSPENSION, EXTENDED RELEASE
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA213586
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51759-850 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RISPERIDONE200 mg/.56mL
Pharmacologic classes
Atypical Antipsychotic [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51759-850-10 | 51759085010 | 1 SYRINGE, GLASS in 1 CARTON (51759-850-10) / .56 mL in 1 SYRINGE, GLASS |
| 51759-850-11 | 51759085011 | 1 SYRINGE, GLASS in 1 CARTON (51759-850-11) / .56 mL in 1 SYRINGE, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/734eb776-4be0-4808-834b-0d8b0f9e021eMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=51759-850NADAC price for package 51759085010
GET /v1/drugs/nadac/51759085010
Use it
Look up 51759-850 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51759-850 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51759-850. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.